Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Classificação em ações #7354
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Preço da ação
$42.98
Última sincronização: 2024-06-21
Valor de mercado
$1.62B
Variação (1 dia)
0.01%
Variação (1 ano)
0.00%
País
IL
Negociar Taro Pharmaceutical Industries Ltd. (TARO)

Categoria

Histórico de preços das ações de Taro Pharmaceutical Industries Ltd. (TARO)
Preço de fecho mais alto: $42.80 em 2024-06-01

Preço de fecho mais baixo: $0.26 em 1982-09-01
Histórico de preços das ações da Taro Pharmaceutical Industries Ltd. de 1982 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 6.64%
2023 36.56%
2022 -41.48%
2021 -29.29%
2020 -23.41%
2019 4.06%
2018 -15.69%
2017 0.21%
2016 -30.16%
2015 5.01%
2014 48.55%
2013 103.08%
2012 66.51%
2011 104.38%
2010 55.00%
2009 8.92%
2008 9.26%
2007 -26.86%
2006 -24.65%
2005 -58.63%
2004 -50.26%
2003 76.86%
2002 -5.77%
2001 184.09%
2000 117.15%
1999 158.57%
1998 5.22%
1997 -24.30%
1996 -4.63%
1995 -1.73%
1994 -8.95%
1993 -15.04%
1992 48.42%
1991 106.59%
1990 107.00%
1989 55.03%
1988 13.94%
1987 -66.84%
1986 -27.89%
1985 134.59%
1984 -37.81%
1983 95.86%
1982 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$171.67 -
DE
$165.71 31.97%
DE
$37.84 25.57%
JP
$223.70 28.32%
CH
$21.19 17.04%
IN